Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2013

01-12-2013 | Original Article

Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture

Authors: Ulla Ludwig, Julia Connemann, Frieder Keller

Published in: Clinical and Experimental Nephrology | Issue 6/2013

Login to get access

Abstract

Background

Intravascular administration of iodinated contrast media continues to be a common cause of hospital-acquired acute kidney injury. Accumulating evidence suggests that radiocontrast agent-induced nephrotoxicity is associated with increased oxidative stress, which leads to renal tissue damage with DNA fragmentation. We therefore tested whether an iso-osmolar contrast medium (iodixanol) causes less oxidative DNA damage to renal tubular cells than a low-osmolar contrast medium (iopromide).

Methods

HK-2 cells (human proximal renal tubular cell line) were incubated at different time points (10 min–2 h) with increasing concentrations (20–120 mg/ml iodine) of iodixanol or of iopromide. Oxidative DNA damage to renal tubular cells was measured by alkaline comet assay (single-cell gel electrophoresis).

Results

Both iso- and low-osmolar contrast agents induced time- and concentration-dependent DNA fragmentation. DNA fragmentation was maximal at 2 h with 120 mg/ml iodine for iopromide (32 ± 27 tail moments) and iodixanol (46 ± 41 tail moments); both were significantly different from the control value with 3.15 ± 1.6 tail moments (Student’s t test; p < 0.001). After 1 and 2 h and for all concentrations, iodixanol produced significantly higher DNA fragmentation than iopromide (ANOVA for 1 h p = 0.039 and 2 h p = 0.025, respectively).

Conclusion

We were able to demonstrate for the first time that an iso-osmolar contrast medium induced even greater oxidative stress and DNA damage than a low-osmolar agent in HK-2 cells. This could provide an explanation for the nephrotoxicity that also is observed with iodixanol in clinical practice.
Literature
1.
go back to reference Heymann SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaption and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008;3:288–96.CrossRef Heymann SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaption and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008;3:288–96.CrossRef
2.
go back to reference Brezis M, Epstein FH. A closer look at radiocontrast-induced nephropathy. N Engl J Med. 1989;320:178–81. Brezis M, Epstein FH. A closer look at radiocontrast-induced nephropathy. N Engl J Med. 1989;320:178–81.
3.
go back to reference Bakris GL, Gass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258:F115–20.PubMed Bakris GL, Gass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258:F115–20.PubMed
4.
go back to reference Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C. Reactive oxygen species in the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45:188–95.PubMedCrossRef Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C. Reactive oxygen species in the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45:188–95.PubMedCrossRef
5.
go back to reference Quintavalle C, Brenca M, De Micco F, Romano MF, Apone F, Bianco A, Zabatta MA, Troncone G, Briguori C, Condorelli G. In vivo and in vitro assessement of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis. 2011;2:e155.PubMedCrossRefPubMedCentral Quintavalle C, Brenca M, De Micco F, Romano MF, Apone F, Bianco A, Zabatta MA, Troncone G, Briguori C, Condorelli G. In vivo and in vitro assessement of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis. 2011;2:e155.PubMedCrossRefPubMedCentral
6.
go back to reference Aruoma OI, Halliwell B, Gajewski E, Dizaroglu M. Copper ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem J. 1991;273:601–4.PubMedPubMedCentral Aruoma OI, Halliwell B, Gajewski E, Dizaroglu M. Copper ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem J. 1991;273:601–4.PubMedPubMedCentral
7.
go back to reference Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R. The comet assay: what can it really tell us? Mutat Res. 1997;375:183–93.PubMedCrossRef Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R. The comet assay: what can it really tell us? Mutat Res. 1997;375:183–93.PubMedCrossRef
8.
go back to reference Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491–9.PubMedCrossRef Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491–9.PubMedCrossRef
9.
go back to reference Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994;45:48–57.PubMedCrossRef Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994;45:48–57.PubMedCrossRef
10.
go back to reference Speit G, Hartmann A. The comet assay (single-cell gel test): a sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol Biol. 1999;113:203–12.PubMed Speit G, Hartmann A. The comet assay (single-cell gel test): a sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol Biol. 1999;113:203–12.PubMed
11.
go back to reference Helma C, Uhl M. A public domain image-analysis program for the single-cell gel-electrophoresis (comet assay). Mutat Res. 2000;466:9–15.PubMedCrossRef Helma C, Uhl M. A public domain image-analysis program for the single-cell gel-electrophoresis (comet assay). Mutat Res. 2000;466:9–15.PubMedCrossRef
12.
go back to reference Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68:14–22.PubMedCrossRef Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68:14–22.PubMedCrossRef
13.
go back to reference Hardiek K, Katholi RE, Ramkumar V. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol. 2001;280:61–70. Hardiek K, Katholi RE, Ramkumar V. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol. 2001;280:61–70.
14.
go back to reference Ueda J, Nygren A, Sjoquist M, Jacobsson E, Ulfendahl HR, Araki Y. Iodine concentrations in the rat kidney measured by X-ray microanalysis. Comparison of concentrations and viscosities in the proximal tubules and renal pelvis after intravenous injections of contrast media. Acta Radiol. 1998;39:90–5.PubMed Ueda J, Nygren A, Sjoquist M, Jacobsson E, Ulfendahl HR, Araki Y. Iodine concentrations in the rat kidney measured by X-ray microanalysis. Comparison of concentrations and viscosities in the proximal tubules and renal pelvis after intravenous injections of contrast media. Acta Radiol. 1998;39:90–5.PubMed
15.
go back to reference Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int. 2006;70:1811–7.PubMedCrossRef Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int. 2006;70:1811–7.PubMedCrossRef
16.
go back to reference Bourin M, Jolliet P, Ballereau F. An overview of the clinical pharmacokinetics of X-ray contrast media. Clin Pharmacokinet. 1997;32:180–93.PubMedCrossRef Bourin M, Jolliet P, Ballereau F. An overview of the clinical pharmacokinetics of X-ray contrast media. Clin Pharmacokinet. 1997;32:180–93.PubMedCrossRef
17.
go back to reference Romano G, Briguori C, Qnintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G. Contrast agents and renal cell apoptosis. Eur Heart J. 2008;29:2569–76.PubMedCrossRef Romano G, Briguori C, Qnintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G. Contrast agents and renal cell apoptosis. Eur Heart J. 2008;29:2569–76.PubMedCrossRef
18.
go back to reference Barret BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006;41:815–21.CrossRef Barret BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006;41:815–21.CrossRef
Metadata
Title
Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture
Authors
Ulla Ludwig
Julia Connemann
Frieder Keller
Publication date
01-12-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0774-z

Other articles of this Issue 6/2013

Clinical and Experimental Nephrology 6/2013 Go to the issue

Images in Nephrology

Polycystic horseshoe kidney

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine